Worldwide Clinical Trials Cocktail Reception
Join Worldwide for Food and Cocktails Monday, November 28, 2022, at the Hilton Union Square Hotel in San Francisco, CA, from 7:30-9:30pm PST.
SPACE IS LIMITED. REGISTER HERE BY NOVEMBER 21!
JOIN US NOVEMBER 28th
Join Worldwide Clinical Trials on Monday, November 28, 2022, at the beautiful Hilton Union Square Hotel to savor an array of delicious appetizers, open bar, and lively conversations.
Located at 333 O' Farrell Street in the Vista Room, Tower 1 on the 45th floor, Hilton Union Square Hotel is in the heart of San Francisco and conveniently located for those attending CTAD.
Enjoy the upbeat venue with a beautiful view of the city. You won't want to miss it!
With any questions leading up to the event, please contact the Marketing team at Marketing@worldwide.com.
QUESTIONS ABOUT THE EVENT?
Ready to learn more about Worldwide? See our service offerings below!
Our personalized approach means we truly partner with you across the entire lifecycle of product development and commercialization.
BIOANALYTICAL SERVICES
- Bioanalytical lab (Austin, TX)
- AME Services
- Assay Method Search
- LC/MS/MS
- Protein Binding
EARLY PHASE I CLINICAL TRIALS
- Phase I Clinical Trials
- Bioequivalence
- Clinical Research Unit (San Antonio, TX)
- Pharmacokinetics
- Pharmacodynamics
LATE PHASE II-III CLINICAL TRIALS
- Phase IIA-III Clinical Trials
- Feasibility / Protocol Development
- Biostatistics
- Clinical Monitoring & Site Management
- Medical Monitoring
- Data Management
- Drug & Supply Depots
- Drug Safety & Pharmacovigilance
- Medical Writing
- Method Development /Validation
- Patient Recruitment / Retention
- Project Management
- Quality Assurance
- Rater Services
- Regulatory Affairs
LATE PHASE III-IV CLINICAL TRIALS
- Phase III-IV Clinical Trials
- Drug Safety & Pharmacovigilance
- Outcomes, Epidemiology & Risk Management
- Registries & Observational Studies
WORLDWIDE EVIDENCE™
- Real-World Evidence
- Evidence Strategy & Planning
- Observational Studies / Patient Registry Services
- Post-Approval Safety Studies
